Expression of LHFPL2 in hepatocellular carcinoma and its association with prognosis after transarterial chemoembolization

doi:10.4240/wjgs.116682

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 6

This Article

(33)

(35)

(0)

(254)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Surg. Jun 27, 2026; 18(6): 116682
Published online Jun 27, 2026. doi: 10.4240/wjgs.116682

Table 2 Comparison of clinical and pathological features between transarterial chemoembolization-resistant and non-resistant groups, n (%)

Variable	TACE-resistant (n = 30)	Non-resistant (n = 30)	χ²/t/Z	P value
Sex			1.200	0.273
Male	18 (60.00)	22 (73.33)
Female	12 (40.00)	8 (26.67)
Age (years), mean ± SD	64.40 ± 10.53	64.27 ± 10.61	0.048	0.962
HBV carrier			6.787	0.010
Yes	22 (73.33)	12 (40.00)
No	8 (26.67)	18 (60.00)
Cirrhosis			3.360	0.067
Yes	16 (53.33)	9 (30.00)
No	14 (46.67)	21 (70.00)
AFP level			-	< 0.001
≥ 400 ng/mL	18 (60.00)	4 (13.33)
< 400 ng/mL	12 (40.00)	26 (86.67)
Tumor size			2.443	0.118
> 3 cm	20 (66.67)	14 (46.67)
≤ 3 cm	10 (33.33)	16 (53.33)
Histologic differentiation			8.131	0.017
Poor	15 (50.00)	5 (16.67)
Moderate	7 (23.33)	15 (50.00)
Well	8 (26.67)	10 (33.33)

TACE: Transarterial chemoembolization; HBV: Hepatitis B virus; AFP: Alpha-fetoprotein.

Full Size Table

Citation: Sun L, Chen K, Zhu XL. Expression of LHFPL2 in hepatocellular carcinoma and its association with prognosis after transarterial chemoembolization. World J Gastrointest Surg 2026; 18(6): 116682
URL: https://www.wjgnet.com/1948-9366/full/v18/i6/116682.htm
DOI: https://dx.doi.org/10.4240/wjgs.116682

Sun L, Chen K, Zhu XL. Expression of LHFPL2 in hepatocellular carcinoma and its association with prognosis after transarterial chemoembolization. World J Gastrointest Surg 2026; 18(6): 116682 [DOI: 10.4240/wjgs.116682]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.